Skip to main content

Tessier-Lavigne Marc's Form 4 filing

Regeneron Pharmaceuticals, Inc. (REGN) · filed Sep 15, 2021

Accession no.
0001708138-21-000080
Filed
Sep 15, 2021
Trade date
Sep 13, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 20 non-derivative transactions and 3 derivative transactions. Open-market sales total $8.18M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tessier-Lavigne MarcCIK 0001437435Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 13, 2021Common StockMOption exerciseAcquired+4,250$273.67+$1,163,097.56,328Direct
Sep 13, 2021Common StockMOption exerciseAcquired+4,250$273.67+$1,163,097.510,578Direct
Sep 13, 2021Common StockMOption exerciseAcquired+4,250$273.67+$1,163,097.514,828Direct
Sep 13, 2021Common StockSSaleDisposed−816$636.64F2−$519,498.2414,012Direct
Sep 13, 2021Common StockSSaleDisposed−816$637.71F3−$520,371.3613,196Direct
Sep 13, 2021Common StockSSaleDisposed−2,098$638.46F4−$1,339,489.0811,098Direct
Sep 13, 2021Common StockSSaleDisposed−1,260$639.45F5−$805,7079,838Direct
Sep 13, 2021Common StockSSaleDisposed−981$640.61F6−$628,438.418,857Direct
Sep 13, 2021Common StockSSaleDisposed−952$641.56F7−$610,765.127,905Direct
Sep 13, 2021Common StockSSaleDisposed−1,645$642.54F8−$1,056,978.36,260Direct
Sep 13, 2021Common StockSSaleDisposed−1,549$643.33F9−$996,518.174,711Direct
Sep 13, 2021Common StockSSaleDisposed−844$644.52F10−$543,974.883,867Direct
Sep 13, 2021Common StockSSaleDisposed−61$645.21F11−$39,357.813,806Direct
Sep 13, 2021Common StockSSaleDisposed−354$646.24F12−$228,768.963,452Direct
Sep 13, 2021Common StockSSaleDisposed−425$647.39F13−$275,140.753,027Direct
Sep 13, 2021Common StockSSaleDisposed−381$648.25F14−$246,983.252,646Direct
Sep 13, 2021Common StockSSaleDisposed−124$649.35F15−$80,519.42,522Direct
Sep 13, 2021Common StockSSaleDisposed−56$650.33−$36,418.482,466Direct
Sep 13, 2021Common StockSSaleDisposed−249$651.54F16−$162,233.462,217Direct
Sep 13, 2021Common StockSSaleDisposed−139$652.26−$90,664.142,078Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 13, 2021Common StockMOption exerciseDisposed−4,250$0.00$08,500Direct
Sep 13, 2021Common StockMOption exerciseDisposed−4,250$0.00$04,250Direct
Sep 13, 2021Common StockMOption exerciseDisposed−4,250$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents volume-weighted average price of sales of 816 shares of Company stock on September 13, 2021 at prices ranging from $636.08 to $636.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents volume-weighted average price of sales of 816 shares of Company stock on September 13, 2021 at prices ranging from $637.26 to $637.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents volume-weighted average price of sales of 2,098 shares of Company stock on September 13, 2021 at prices ranging from $638.00 to $638.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents volume-weighted average price of sales of 1,260 shares of Company stock on September 13, 2021 at prices ranging from $639.00 to $639.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Represents volume-weighted average price of sales of 981 shares of Company stock on September 13, 2021 at prices ranging from $640.18 to $640.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Represents volume-weighted average price of sales of 952 shares of Company stock on September 13, 2021 at prices ranging from $641.01 to $641.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

Represents volume-weighted average price of sales of 1,645 shares of Company stock on September 13, 2021 at prices ranging from $642.00 to $642.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F9

Represents volume-weighted average price of sales of 1,549 shares of Company stock on September 13, 2021 at prices ranging from $643.01 to $643.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

Represents volume-weighted average price of sales of 844 shares of Company stock on September 13, 2021 at prices ranging from $644.03 to $644.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F11

Represents volume-weighted average price of sales of 61 shares of Company stock on September 13, 2021 at prices ranging from $645.21 to $645.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F12

Represents volume-weighted average price of sales of 354 shares of Company stock on September 13, 2021 at prices ranging from $646.04 to $646.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F13

Represents volume-weighted average price of sales of 425 shares of Company stock on September 13, 2021 at prices ranging from $647.06 to $647.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F14

Represents volume-weighted average price of sales of 381 shares of Company stock on September 13, 2021 at prices ranging from $648.06 to $648.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F15

Represents volume-weighted average price of sales of 124 shares of Company stock on September 13, 2021 at prices ranging from $649.27 to $649.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F16

Represents volume-weighted average price of sales of 249 shares of Company stock on September 13, 2021 at prices ranging from $651.10 to $651.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)